Revlimid, Celgene
Revlimid-Rituximab Combo Approved for FL and MZL
The FDA approved lenalidomide (Revlimid, Celgene) in combination with a rituximab product for previously treated ...
JUNE 4, 2019
In High-Risk MM, Early Allo-HCT Appears Advantageous
San Diego—The trend of delaying allogeneic hematopoietic cell transplantation (allo-HCT) in multiple myeloma ...
MAY 4, 2017
Load more